Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIAN HEALTHCARE vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CIAN HEALTHCARE   MYLAN
EQUITY SHARE DATA
    CIAN HEALTHCARE
Mar-23
MYLAN
Dec-18
CIAN HEALTHCARE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs323,967-   
Low Rs122,184-   
Sales per share (Unadj.) Rs27.41,825.4-  
Earnings per share (Unadj.) Rs0.849.6-  
Cash flow per share (Unadj.) Rs3.0391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs23.01,974.7-  
Shares outstanding (eoy) m25.00514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.81.7 47.5%   
Avg P/E ratio x27.062.0 43.6%  
P/CF ratio (eoy) x7.47.9 93.6%  
Price / Book Value ratio x1.01.6 61.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m5491,582,214 0.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m890-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m686939,158 0.1%  
Other income Rs m60-   
Total revenues Rs m692939,158 0.1%   
Gross profit Rs m131243,019 0.1%  
Depreciation Rs m54175,847 0.0%   
Interest Rs m6345,170 0.1%   
Profit before tax Rs m2022,002 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0-3,500 0.0%   
Profit after tax Rs m2025,502 0.1%  
Gross profit margin %19.125.9 73.8%  
Effective tax rate %-1.9-15.9 12.2%   
Net profit margin %3.02.7 109.0%  
BALANCE SHEET DATA
Current assets Rs m742524,425 0.1%   
Current liabilities Rs m653382,364 0.2%   
Net working cap to sales %13.115.1 86.5%  
Current ratio x1.11.4 82.9%  
Inventory Days Days9484 112.8%  
Debtors Days Days1,39693 1,495.9%  
Net fixed assets Rs m762182,181 0.4%   
Share capital Rs m250500 50.0%   
"Free" reserves Rs m3250-   
Net worth Rs m5751,015,998 0.1%   
Long term debt Rs m2941,096,588 0.0%   
Total assets Rs m1,6052,725,301 0.1%  
Interest coverage x1.31.5 88.5%   
Debt to equity ratio x0.51.1 47.4%  
Sales to assets ratio x0.40.3 124.0%   
Return on assets %5.22.6 200.1%  
Return on equity %3.52.5 140.7%  
Return on capital %9.53.2 300.1%  
Exports to sales %13.70-   
Imports to sales %00-   
Net fx Rs m940-   
CASH FLOW
From Operations Rs m48195,157 0.0%  
From Investments Rs m26-100,875 -0.0%  
From Financial Activity Rs m-74-90,916 0.1%  
Net Cashflow Rs m01,617 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare CIAN HEALTHCARE With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare CIAN HEALTHCARE With: COLINZ LABOR  ASTRAZENECA PHARMA  SUVEN LIFE SCIENCES  BAJAJ HEALTHCARE  GANGA PHARMACEUTICALS  



Today's Market

Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5% Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.